
The increasing global prevalence of obesity unequivocally demonstrates that neither zzso zzso and zzso nor pharmacological approaches to this health problem are zzso In this area of high zzso clinical need, the zzso zzso has generated enormous interest amongst academic and pharmaceutical industry scientists as a molecular target for the development of a new generation of safe and more effective zzso zzso In this review, we have described the major developments that have occurred in the fields of the medicinal chemistry and pharmacology of zzso zzso with particular emphasis on their potential application as novel zzso zzso The last 5 years have witnessed an increasing understanding of the zzso zzso and its structural requirements that has produced an explosion in the number and diversity of novel, highly selective zzso zzso zzso partial zzso and zzso that have been designed and zzso In animal models, zzso zzso zzso of all functional types have been shown to decrease food intake when given acutely and zzso to evoke profound and sustained weight-loss in obese animals, and zzso to improve a number of zzso risk zzso zzso studies in obese animal models, which are highly zzso of clinical zzso indicate that zzso zzso may have the potential to be more zzso in the treatment of obesity than the current generation of zzso zzso 

